Please meet Chrissy Bell, Global Connected Health Initiative Leader for 3M DDSD.
The experts at 3M Drug Delivery Systems are the driving force behind 3M’s proud record of successful innovation. They work tirelessly to create products on the cutting edge of the industry and meet the needs of 3M’s partners. We are pleased to introduce one of those experts to you now. Meet Steve Stein, 3M Lead Inhalation Research Specialist.
As we observe Breast Cancer Awareness Month, we are also faced with the grim reality that cancer in all forms is a growing threat to the health of men, women and children around the world.
It is a memory that still brings Charlie Thiel to tears. Back in 1995, he met an elderly Australian doctor who suffered from asthma. “He gave me a bear hug and told me, ‘Charlie, if it weren't for your invention, I would be dead.’
I am a senior technical specialist in the Research and Development organization, working on inhalation drug delivery. My role is principally hardware development (inhaler devices, valves, actuators, dose counters and exciting next generation stuff, such as the 3M Intelligent Control Inhaler).
Have you ever gone into a ‘big box’ store, trying to find a particular item? Attempting to locate anything in those stores amidst so many products and aisles can feel like you’re working to find a needle in a haystack. However, with current technology, it’s possible to type in the product on your smartphone and find exactly where your product is located and how many are in stock.
At 3M Drug Delivery Systems, asthma is a disease we are focused on every day. We have a long history of innovation in inhalation therapy and are constantly working to find new ways to improve the lives of patients.
You’ve probably heard from the financial planning gurus about all the money you could save if you stop drinking that £5 latte every day for a year (it’s about £1,800 if you don’t want to do the maths…). But what if you REALLY want that latte, maybe even feel you NEED that latte to get you through the day? Maybe you shop around a bit and find an equivalent cup of coffee for, say, £1.50. That’s a pretty sharp saving each year (again, with the math... about £1,250).
The conference focuses on the developing issues surrounding aerosol drug delivery. It will be held April 25-28 in Nice, France.
A year ago, 3M’s Drug Delivery Systems, in partnership with Mylan, launched SirduplaTM in the UK as the first therapeutic equivalent to combination asthma therapy Seretide® Evohaler®. With that launch, 3M took an important step forward in the generics space. The partnership combined 3M’s expertise in inhalation drug development and manufacturing with Mylan’s leadership position in the global generics market.
The demographics of an aging population in conjunction with the increasing velocity of technological advancements are dramatically shifting the face of healthcare around the world. This shift is forcing businesses to rethink their business models and portfolios to better align with these new realities.
At 3M Drug Delivery Systems, one of the many ways in which we drive innovation is by constantly gathering information from as many places as possible.
Subscribe to receive update notifications on:
All you need to do is to let us know that you’re in.
All fields are required unless indicated optional
Please be aware that this information (including the original and the subsequent reply) may be transferred to a server located in the U.S. for metrics and storage. If you do not consent to this use of your personal information, please do not use this system.
Your form was submitted successfully!
An error has occurred while submitting. Please try again later...